• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety
TriNetX Announces the Appointment of Shields Carstarphen as Chief Commercial Officer

TriNetX Announces the Appointment of Shields Carstarphen as Chief Commercial Officer

Jan 17, 2023 | Press Releases

Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...
TriNetX-enabled research drives learning at ASH 2022

TriNetX-enabled research drives learning at ASH 2022

Jan 6, 2023 | Blog, Events, Published Research

In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...
South Tees Hospitals NHS Foundation Trust Joins TriNetX to Increase Research Opportunities

South Tees Hospitals NHS Foundation Trust Joins TriNetX to Increase Research Opportunities

Dec 15, 2022 | Press Releases

Cambridge, MA, December 15, 2022 — South Tees Hospitals NHS Foundation Trust, one of the most active research organizations in the northeast of England, has joined the TriNetX network to increase its visibility to commercial partners for additional research...
TriNetX Launches LUCID Trusted Research Environment for Real-World Evidence Generation

TriNetX Launches LUCID Trusted Research Environment for Real-World Evidence Generation

Oct 20, 2022 | Press Releases

Researchers can now run complex data analytics and artificial intelligence/machine learning using TriNetX to unlock new opportunities with remarkable clinical detail Cambridge, MA, October 20, 2022 — TriNetX, the global network of healthcare organizations driving...

TriNetX Acquires European Regulatory-Grade Real-World Evidence Leader OncologyInformationService and CancerDataNet

Oct 18, 2022 | Press Releases

Cambridge, MA, October 18, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the acquisition of OncologyInformationService e.K. (OIS) and its subsidiary...

Leading Comprehensive Cancer Center in France, Centre Léon Bérard, Joins the TriNetX Network to Improve Access to Innovative Therapies for Its Patients

Sep 9, 2022 | Press Releases

Lyon, France, September 9, 2022 – Centre Léon Bérard (CLB), a Comprehensive Cancer Center in Lyon and Rhône-Alpes has joined the TriNetX global health research network. The TriNetX Network is comprised of healthcare organizations and life sciences companies...

TriNetX Develops New Analytics Course with The University of Texas Medical Branch

Aug 10, 2022 | Press Releases

Course Focuses on Integrating the Use of TriNetX with Biomedical Informatics Curriculum Cambridge, MA, August 10, 2022 — TriNetX, LLC partnered with The University of Texas Medical Branch (“UTMB”) on a new research and analytics course titled: Biomedical Informatics:...
Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX

Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX

Jul 29, 2022 | Press Releases

Cambridge, MA, July 29, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the inaugural members of the Pediatric Collaboratory Network (PCN), comprised of...

Finnish Biobanks (FINBB) Partners with TriNetX to Increase Clinical and Biomedical Trials in Finland

Jun 14, 2022 | Press Releases

Cambridge, MA, June 14, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Finnish Biobanks (FINBB), a cooperative owned by the six largest hospital...

TriNetX Launches Prospective Patient Monitoring Platform Leveraging Global Real-World Data

May 13, 2022 | Press Releases

TriNetX Follow the Patient enables the generation of real-world evidence for prospective monitoring studies Cambridge, MA, May 13, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new...
« Older Entries
Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information